The gastric precancerous cascade

被引:573
作者
Correa, Pelayo [1 ]
Piazuelo, M. Blanca [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN 37232 USA
关键词
dysplasia; gastric carcinoma; intestinal metaplasia; precancerous cascade; HELICOBACTER-PYLORI INFECTION; TERM-FOLLOW-UP; METAPLASIA TYPE-III; HIGH-RISK AREA; INTESTINAL METAPLASIA; HUMAN STOMACH; PRENEOPLASTIC LESIONS; CANCER-EPIDEMIOLOGY; ATROPHIC GASTRITIS; CARCINOGENESIS;
D O I
10.1111/j.1751-2980.2011.00550.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Invasive gastric carcinoma is preceded by a cascade of precancerous lesions. The first recognized histologic change is active chronic inflammation, which may persist as such: non-atrophic chronic gastritis (no gland loss), or advance to multifocal atrophic gastritis (MAG), the first real step in the precancerous cascade. The following steps are: intestinal metaplasia (first complete and then incomplete); dysplasia, first low grade and then high grade (equivalent to carcinoma in situ). The following step is invasive carcinoma, which is thought to be associated with degradation of the intercellular matrix.
引用
收藏
页码:2 / 9
页数:8
相关论文
共 40 条
  • [1] Urokinase plasminogen activator receptor is expressed in invasive cells in gastric carcinomas from high- and low-risk countries
    Alpizar-Alpizar, Warner
    Nielsen, Boye Schnack
    Sierra, Rafaela
    Illemann, Martin
    Ramirez, Jose A.
    Arias, Adriana
    Duran, Sundry
    Skarstein, Arne
    Ovrebo, Kjell
    Lund, Leif R.
    Laerum, Ole D.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (02) : 405 - 415
  • [2] HELICOBACTER-ASSOCIATED GASTRITIS IN SCID MICE
    BLANCHARD, TG
    CZINN, SJ
    NEDRUD, JG
    REDLINE, RW
    [J]. INFECTION AND IMMUNITY, 1995, 63 (03) : 1113 - 1115
  • [3] Review article: immunological determinants that may affect the Helicobacter pylori cancer risk
    Blanchard, TG
    Czinn, SJ
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 : 83 - 90
  • [4] Bonne C., 1938, American Journal of Cancer, V33, P265
  • [5] MORBIDITY AND MORTALITY FROM CANCER IN CALI COLOMBIA
    CORREA, P
    LLANOS, G
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1966, 36 (04): : 717 - +
  • [6] CORREA P, 1970, J NATL CANCER I, V44, P297
  • [7] Correa P, 1980, Front Gastrointest Res, V6, P98
  • [8] Chemoprevention of gastric dysplasia:: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy
    Correa, P
    Fontham, ETH
    Bravo, JC
    Bravo, LE
    Ruiz, B
    Zarama, G
    Realpe, JL
    Malcom, GT
    Li, D
    Johnson, WD
    Mera, R
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (23): : 1881 - 1888
  • [9] CORREA P, 1975, LANCET, V2, P58
  • [10] CORREA P, 1988, CANCER RES, V48, P3554